We characterized the clinical phenotype of severe (n = 21), mild (n = 7) and risk (n = 39) GBA1 carriers and non-carriers (n = 554) only in unrelated PD patients excluding carriers with only one synonymous or VUS variant in individuals remaining after the filtering step. This evidence concerns the gene GBA1 and Parkinson disease.